Inloggad som:
DSC-BROMS-1
Är du som patient intresserad av mer information om en studie, kontakta din behandlande läkare.
DSC-BROMS-1
En randomiserad studie jämförande DSC och BAT som behandling av kortison-refraktär akut GVHD efter allogen SCT
Safety Trial, DSC vs. BAT in SR acute GvHD
Akademiska sjukhuset / Hematologisk vård
A multicenter, open-label, randomized, phase II clinical trial comparing safety and durable
overall response rate (DOR) at 56 days in patients with steroid resistant severe acute GvHD
after allogeneic hematopoietic stem cell transplantation treated with decidua stromal cells
(DSC) or best available treatment (BAT)
Mer information om studien för vårdgivare
Adult patients (age ≥ 18 years) with steroid refractory acute GvHD grades II-IV after allo-HSCT.
Signed informed consent form once SR-aGvHD is confirmed.
Presence of an active uncontrolled infection including significant bacterial, fungal, viral or parasitic infection
requiring treatment. Has received systemic treatment for aGvHD apart from steroids. Clinical presentation resembling de novo chronic GvHD or GvHD overlap syndrome. See protocol for info
Behandling
Fas 2
Kurativ
Ej tillämpbar
Akademisk
Studien ändrades senast: (2025-09-30)